JXSS2101027 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-10-29 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | | | view |
JYSB2300210 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2023-12-09 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | | | view |
JYSZ2200059 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | License Renew | 2022-11-04 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSS2400039 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-04-18 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSS2400061 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-07-19 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSL2101047 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-06-29 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JYSB2200075 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | | | view |
JYSZ2200060 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | License Renew | 2022-11-04 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JYSB2300209 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2023-12-09 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | | | view |
JXSS2400015 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-24 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSB2101075 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2021-10-22 | | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company | | | view |
JXSS2101021 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-15 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSB2101113 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2021-12-27 | | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company | | | view |
JXSS2400062 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-07-19 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSB2300139 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2023-11-30 | | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company | | | view |
JXSS2200015 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-04-22 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | | | view |
JXSS2400014 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-24 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSL2101138 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-24 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSS2101019 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-15 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
JXSS2400059 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-07-17 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |